A detailed history of Boston Family Office LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Boston Family Office LLC holds 53,624 shares of MRK stock, worth $5.46 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
53,624
Previous 51,507 4.11%
Holding current value
$5.46 Million
Previous $6.8 Million 2.31%
% of portfolio
0.48%
Previous 0.49%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $262,084 - $281,476
2,117 Added 4.11%
53,624 $6.64 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $6,567 - $7,653
-58 Reduced 0.11%
51,507 $6.8 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $156,080 - $169,853
-1,558 Reduced 2.93%
51,565 $5.62 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $62,490 - $69,398
607 Added 1.16%
53,123 $5.47 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $73,094 - $79,669
-673 Reduced 1.27%
52,516 $6.06 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $10,396 - $11,600
101 Added 0.19%
53,189 $5.66 Million
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $184,585 - $236,664
-2,111 Reduced 3.82%
53,088 $5.89 Million
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $344,290 - $386,772
-4,073 Reduced 6.87%
55,199 $4.75 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $277,103 - $314,110
3,319 Added 5.93%
59,272 $5.4 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $55,573 - $62,294
756 Added 1.37%
55,953 $4.59 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $24,575 - $30,783
340 Added 0.62%
55,197 $4.23 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $322,273 - $354,419
-4,496 Reduced 7.58%
54,857 $4.12 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $363,291 - $401,837
-5,167 Reduced 8.01%
59,353 $4.62 Million
Q1 2021

May 07, 2021

SELL
$68.86 - $81.11 $997,850 - $1.18 Million
-14,491 Reduced 18.34%
64,520 $5.36 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $761,264 - $844,847
-10,607 Reduced 11.84%
79,011 $6.46 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $52,543 - $59,558
718 Added 0.81%
89,618 $7.43 Million
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $115,418 - $131,333
-1,639 Reduced 1.81%
88,900 $6.88 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $385,545 - $534,384
-6,085 Reduced 6.3%
90,539 $6.97 Million
Q4 2019

Feb 05, 2020

SELL
$77.58 - $87.54 $34,367 - $38,780
-443 Reduced 0.46%
96,624 $8.79 Million
Q2 2019

Jul 30, 2019

BUY
$69.84 - $81.59 $6,355 - $7,424
91 Added 0.09%
97,067 $8.14 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $352,422 - $401,958
-5,065 Reduced 4.96%
96,976 $8.07 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $344,336 - $399,597
-5,278 Reduced 4.92%
102,041 $7.8 Million
Q3 2018

Nov 01, 2018

SELL
$57.69 - $67.84 $2,942 - $3,459
-51 Reduced 0.05%
107,319 $7.61 Million
Q2 2018

Jul 26, 2018

BUY
$50.83 - $59.72 $85,597 - $100,568
1,684 Added 1.59%
107,370 $6.52 Million
Q1 2018

Apr 30, 2018

SELL
$50.96 - $59.23 $85,561 - $99,447
-1,679 Reduced 1.56%
105,686 $5.76 Million
Q4 2017

Feb 06, 2018

BUY
$51.62 - $61.64 $2,064 - $2,465
40 Added 0.04%
107,365 $6.04 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $6.3 Million - $6.78 Million
107,325
107,325 $6.87 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.